ALKS
Companies
NASDAQ
Alkermes plc
Health Care
$29.32
+$0.56 (+1.95%)
Price Chart
Overview
About ALKS
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Market Cap
$4.0B
Volume
35.1M
Avg. Volume
53.1M
P/E Ratio
15.756219
Dividend Yield
0.00%
Employees
2.3K
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Website
Latest News for ALKS
Risk & Correlation Analysis
Market Correlation
0.47
Low Correlation
Volatility
Medium (0.33)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ALKS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$4.0B
Volume35.1M
P/E Ratio15.76
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 1, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025